In summary, our results supported the notion that altered SPDL1 expression in CRC tissue might predict patient outcome, and mechanistically this was likely attributable, at least partially, to tipping the balance of chromosomal instability toward the detriment of tumor overall longevity. The gene discussed is SPDL1; the disease is neoplasm.